| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.31▼ | 1.26▲ | 1.26▲ | 1.31▼ | 1.59▼ |
| MA10 | 1.29▲ | 1.25▲ | 1.20▲ | 1.49▼ | 1.75▼ |
| MA20 | 1.26▲ | 1.18▲ | 1.19▲ | 1.67▼ | 2.26▼ |
| MA50 | 1.21▲ | 1.29▲ | 1.46▼ | 1.91▼ | 3.26▼ |
| MA100 | 1.20▲ | 1.49▼ | 1.66▼ | 2.51▼ | N/A |
| MA200 | 1.43▼ | 1.68▼ | 1.75▼ | 3.14▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.026▲ | 0.037▲ | -0.042▼ | 0.160▲ |
| RSI | 61.277▲ | 61.037▲ | 51.280▲ | 33.937▼ | 33.586▼ |
| STOCH | 93.333▲ | 80.017▲ | 90.325▲ | 19.493▼ | 11.839▼ |
| WILL %R | -21.429▲ | -11.538▲ | -10.714▲ | -64.486 | -92.017▼ |
| CCI | 74.171 | 129.946▲ | 144.930▲ | -104.405▼ | -110.756▼ |
|
Thursday, September 24, 2026 05:00 AM
In a preclinical chronic colitis model, Tvardi’s oral small molecule accumulated in the colon at approximately 8-fold higher concentrations than in plasma, at pharmacologically relevant levels, and ...
|
|
Sunday, September 20, 2026 08:17 PM
Tvardi Therapeutics, Inc., formerly Cara Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting (STAT3) to ...
|
|
Wednesday, August 12, 2026 01:00 AM
HOUSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/09/26 | 1.27 | 1.35 | 1.20 | 1.31 | 271,925 |
| 25/09/26 | 1.14 | 1.28 | 1.07 | 1.27 | 651,986 |
| 24/09/26 | 1.30 | 1.33 | 0.93 | 1.06 | 609,400 |
| 23/09/26 | 1.59 | 1.61 | 1.255 | 1.32 | 412,100 |
| 22/09/26 | 1.65 | 1.72 | 1.58 | 1.59 | 115,620 |
| 21/09/26 | 1.65 | 1.66 | 1.57 | 1.61 | 186,100 |
| 18/09/26 | 1.615 | 1.65 | 1.61 | 1.61 | 119,838 |
| 17/09/26 | 1.71 | 1.745 | 1.61 | 1.61 | 192,878 |
| 16/09/26 | 1.75 | 1.795 | 1.735 | 1.74 | 111,823 |
| 15/09/26 | 1.81 | 1.82 | 1.74 | 1.755 | 103,358 |
|
|
||||
|
|
||||
|
|